Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Profit After Tax (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Profit After Tax for 12 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax rose 62.94% year-over-year to -$1.2 million, compared with a TTM value of -$5.2 million through Sep 2025, up 33.6%, and an annual FY2024 reading of -$7.0 million, up 49.66% over the prior year.
  • Profit After Tax was -$1.2 million for Q3 2025 at Arcadia Biosciences, down from -$501000.0 in the prior quarter.
  • Across five years, Profit After Tax topped out at $1.7 million in Q1 2021 and bottomed at -$10.8 million in Q4 2021.
  • Average Profit After Tax over 5 years is -$2.6 million, with a median of -$2.3 million recorded in 2022.
  • The sharpest move saw Profit After Tax tumbled 1671.05% in 2023, then skyrocketed 155.97% in 2025.
  • Year by year, Profit After Tax stood at -$10.8 million in 2021, then surged by 102.83% to $304000.0 in 2022, then crashed by 1671.05% to -$4.8 million in 2023, then increased by 15.45% to -$4.0 million in 2024, then soared by 71.42% to -$1.2 million in 2025.
  • Business Quant data shows Profit After Tax for RKDA at -$1.2 million in Q3 2025, -$501000.0 in Q2 2025, and $530000.0 in Q1 2025.